Welcome to Diazyme Laboratories - Innovating Healthcare with Advanced Diagnostics

Diazyme Laboratories Inc., a leader in innovative diagnostic solutions, is dedicated to advancing healthcare through proprietary enzyme and immunoassay technologies. We specialize in the research and development, manufacture, and distribution of accurate, high-quality diagnostic reagents that can be used on user-friendly automated analyzers. With a commitment to excellence, our cutting-edge products are trusted by healthcare professionals worldwide.

New Arrivals

ApoE4 Test Kit COMING SOON

ApoE4 Test Kit

Coming Soon! INTENDED USE: The Diazyme ApoE4 Test Kit is designed to qualitatively determine the presence of ApoE4 antigens in human plasma. The test allows to determine if a sample is ApoE4 negative...

Request Quote
pTau-217 CLIA KIT COMING SOON

pTau-217 CLIA KIT

Coming Soon! INTENDED USE: Diazyme pTau-217 CLIA Kit is for the quantitative determination of Phosphorylated Tau 217 (pTau-217) concentration in EDTA plasma on chemiluminescence analyzer. USA: For...

Request Quote
AMYLOID-β42 CLIA KIT COMING SOON

AMYLOID-β42 CLIA KIT

Coming Soon! INTENDED USE: Diazyme Aβ42 CLIA Kit is for the quantitative determination of Aβ42 concentration in EDTA plasma on chemiluminescence analyzer. USA: For Research Use Only. Not for use in...

Request Quote
AMYLOID-β40 CLIA KIT COMING SOON

AMYLOID-β40 CLIA Kit

Coming Soon! INTENDED USE: Diazyme Aβ40 CLIA Kit is for the quantitative determination of Aβ40 concentration in EDTA plasma on chemiluminescence analyzer. USA: For Research Use Only. Not for use in...

Request Quote
pTau-181 Assay COMING SOON

pTau-181 CLIA KIT

Coming Soon! INTENDED USE: Diazyme pTau-181 CLIA Kit is for the quantitative determination of Phosphorylated Tau 181 (pTau-181) concentration in EDTA plasma on chemiluminescence analyzer. USA: For...

Request Quote

Products View all

Recent Announcements

Introducing Diazyme’s Blood-Based Neurological Biomarker Panel for Advanced Research

30th Apr 2025

In response to the rising global demand for innovative and accessible tools in neurodegenerative disease research, Diazyme is excited to unveil a new panel of six blood-based neuro…
read more

How Diazyme’s Kappa & Lambda Free Light Chain Assays Are Improving Diagnostic Confidence – A Testimonial from James DiPhilippo, Laboratory Director at New England Cancer Specialists

30th Apr 2025

Improving Oncology Diagnostics with Diazyme’s Free Light Chain Assays In the fight against multiple myeloma and related plasma cell disorders, speed and accuracy in diagnosti…
read more

Mastering Sample Collection: Diazyme’s Extraction Device Videos for Calprotectin, Lactoferrin, and Pancreatic Elastase Assays

10th Jan 2025

Accurate sample preparation is crucial for reliable diagnostic testing, and Diazyme is committed to making this process as simple and efficient as possible. To support laboratories…
read more